Genome-wide CRISPR Screening Identifies NFκB and c-MET as Druggable Targets to Sensitize Lenvatinib Treatment in Hepatocellular Carcinoma
T.S.K. Wan(University of Hong Kong), Chun‐Ming Wong(University of Hong Kong)
Cited by 2
Related Papers
Glucose oxidase: natural occurrence, function, properties and industrial applications
|Applied Microbiology and Biotechnology|2008|535
Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC
|Nature Communications|2019|441
Up‐regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis
|Hepatology|2015|165
Bromodomain-containing protein BRPF1 is a therapeutic target for liver cancer
|Communications Biology|2021|43